Publication:
Analysis of pleural effusions using flow cytometry

dc.contributor.authorsCeyhan, BB; Demiralp, E; Celikel, T
dc.date.accessioned2022-03-12T16:56:23Z
dc.date.accessioned2026-01-11T13:39:02Z
dc.date.available2022-03-12T16:56:23Z
dc.date.issued1996
dc.description.abstractFlow cytometry allows a rapid and accurate analysis of the cells in serous fluids. The aim of this study was to evaluate the use of flow cytometric analysis in malignant pleural effuions. 26 patients (13 females, 13 males; mean age 52 +/- 19 years; range 16-82) were included in the study. 15 had malignant pleural effusions (7 adenocarcinoma, 2 lymphoma, 2 chronic myeloid leukemia, 1 ovarian carcinoma, 1 small cell lung carcinoma, 1 squamous cell lung carcinoma and empyema, and 1 malignant mesothelioma) with positive cytology. 2 had benign effusions associated with malignancy (1 squamous cell lung carcinoma and congestive heart failure, and 1 neuroblastoma and hypoproteinemia). 9 had benign effusions (3 tuberculosis, 1 congestive heart failure, 3 para-pneumonic pleural effusion, 1 benign mesothelioma, and 1 pulmonary embolism). Flow cytometric analysis of pleural effusions revealed an increased DNA index in malignant effusions: 1.32 +/- 0.44 versus 0.88 +/- 0.23 in benign effusions (p < 0.04). The cell cycle distribution of cells such as G(1)/G(0) and S in malignant effusions did not differ from that of benign pleural effusions; however G(2)+M increased significantly in malignant effusions (p < 0.03). Using analysis of mononuclear immunophenotyping, CD3+, CD4+, and CD8+ cells did not show any significant difference between the two groups. The lymphocyte activation marker CD38 was positive in 57.6 +/- 11.5 % of malignant fluid cells and 38.5 +/- 6.2% of benign fluid cells (p < 0.04). The mean carcinoembryonic antigen levels in malignant and benign pleural effusions were 98.7 +/- 157.3 and 0.9 +/- 1.2 ng/ml, respectively (p < 0.03). In conclusion, the results of our study indicate that finding cells with an abnormal DNA content strongly supports the diagnosis of malignant pleural effusions. Additionally, mononuclear cell phenotypes have to be taken into consideration for malignant pleural effusions, particularly activated T cells. We recommend that flow cytometry should be performed if the cytology is equivocal.
dc.identifier.doidoiWOS:A1996TV20900003
dc.identifier.issn0025-7931
dc.identifier.pubmed8833988
dc.identifier.urihttps://hdl.handle.net/11424/226746
dc.identifier.wosWOS:A1996TV20900003
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofRESPIRATION
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectpleural effusions
dc.subjectflow cytometry
dc.subjectDNA index
dc.subjectmononuclear cell phenotyping
dc.subjectCELL-SURFACE ANALYSIS
dc.subjectNUCLEAR-DNA CONTENT
dc.subjectBODY CAVITY FLUIDS
dc.subjectLUNG-CANCER
dc.subjectLYMPHOCYTE-T
dc.subjectCARCINOEMBRYONIC ANTIGEN
dc.subjectDIFFERENTIAL-DIAGNOSIS
dc.subjectMALIGNANT EFFUSIONS
dc.subjectPERIPHERAL-BLOOD
dc.subjectIMAGE-ANALYSIS
dc.titleAnalysis of pleural effusions using flow cytometry
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage24
oaire.citation.issue1
oaire.citation.startPage17
oaire.citation.titleRESPIRATION
oaire.citation.volume63

Files